- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05027763
Effect of Preoperative Diet on Perioperative Gut Microbiome
Can Low-fat/high-fiber or Fermented Diet Modulate the Gut Microbiome to Improve Surgical Outcomes?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Standard of care: patients undergoing major abdominal colorectal surgery are sometimes advised to eat healthfully prior to surgery, but without more specific recommendations regarding their diet.
Research Activities:
- Screening: eligible patients will be identified through screening the clinic schedules.
- Enrollment: in person or remotely, after the patient is determined to require major abdominal surgery, they will be invited to participate in the study. If they consent to participate, they will be randomized to receive either low-fat/high-fiber diet, high-fermented diet, or continue with their normal diet for 10-14 days prior to the surgery.
Intervention: at baseline, data will be collected regarding clinical information of the patients (age, body mass index, comorbidities, medications or supplements, physical activity levels, antibiotic or probiotic use in the past six months), and baseline dietary pattern, which will be evaluated through application of a validated Food Frequency Questionnaire (DHQ III). Patients in the intervention arms (low- fat/high-fiber diet or high-fermented diet) will receive meal samples during the 10-14 days preceding surgery. Patients in the control arm will receive a $25 grocery voucher. Adherence to the diet will be assessed through regular check ins with the patients.
Stool samples will be collected in five timepoints: at the beginning of the study, after the dietary intervention, during surgery, in the first week after the surgery, and between 21-30 days after surgery. The stool samples will be sent for analysis of the microbiome.
A fragment of the resected bowel will also be sent for analysis of the mucosal-associated microbiome.
- Closeout: After surgery, all patients will receive the same standard dietary protocol and care, and will be followed for 30 days without any further intervention.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford Health Care
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- undergoing major abdominal colorectal surgery with intestinal resection in 2 or more weeks
Exclusion Criteria:
- patients who do not speak English or Spanish
- houseless patients
- decisionally impaired patients
- presence of ileostomy prior to the surgical procedure
- surgery without intestinal resection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Arm
Standard care - patients will not receive specific dietary advice.
|
|
|
Experimental: High Fiber/low fat
Patients will receive sample meals and education/support, will be asked to follow this diet for 10 days.
|
high fiber/low fat preoperative diet
|
|
Experimental: Fermented
Patients will receive sample meals and education/support, will be asked to follow this diet for 10 days.
|
fermented preoperative diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in gut microbiome alpha and beta diversity according to pre-operative diet intervention
Time Frame: Two weeks prior to surgery
|
Metagenomic sequencing will be performed on stool samples before and after dietary change.
|
Two weeks prior to surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in gut microbiome alpha and beta diversity after surgery according to pre-operative diet
Time Frame: Surgery date until 1 month after surgery
|
Metagenomic sequencing will be performed on stool samples collected in the first week after surgery and 30 days after surgery
|
Surgery date until 1 month after surgery
|
|
Frequency and severity of surgical complications according to pre-operative diet
Time Frame: 30 days after surgery
|
Comprehensive Complication Index (CCI) score will be used to measure number and severity of surgical complications occurring within 30 days after surgery.
Comprehensive Complication Index score includes minimum value of 0 and maximum value of 100; higher score means higher severity of complication(s).
|
30 days after surgery
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Slankamenac K, Nederlof N, Pessaux P, de Jonge J, Wijnhoven BP, Breitenstein S, Oberkofler CE, Graf R, Puhan MA, Clavien PA. The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg. 2014 Nov;260(5):757-62; discussion 762-3. doi: 10.1097/SLA.0000000000000948.
- Wastyk HC, Fragiadakis GK, Perelman D, Dahan D, Merrill BD, Yu FB, Topf M, Gonzalez CG, Van Treuren W, Han S, Robinson JL, Elias JE, Sonnenburg ED, Gardner CD, Sonnenburg JL. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021 Aug 5;184(16):4137-4153.e14. doi: 10.1016/j.cell.2021.06.019. Epub 2021 Jul 12.
- Kok DE, Arron MNN, Huibregtse T, Kruyt FM, Bac DJ, van Halteren HK, Kouwenhoven EA, Wesselink E, Winkels RM, van Zutphen M, van Duijnhoven FJB, de Wilt JHW, Kampman E. Association of Habitual Preoperative Dietary Fiber Intake With Complications After Colorectal Cancer Surgery. JAMA Surg. 2021 Jun 16;156(9):1-10. doi: 10.1001/jamasurg.2021.2311. Online ahead of print.
- Hyoju SK, Adriaansens C, Wienholts K, Sharma A, Keskey R, Arnold W, van Dalen D, Gottel N, Hyman N, Zaborin A, Gilbert J, van Goor H, Zaborina O, Alverdy JC. Low-fat/high-fibre diet prehabilitation improves anastomotic healing via the microbiome: an experimental model. Br J Surg. 2020 May;107(6):743-755. doi: 10.1002/bjs.11388. Epub 2019 Dec 26.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 62330
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgical Site Infection
-
Gundersen Lutheran Medical FoundationGundersen Lutheran Health SystemCompletedSurgical Site Infection | Superficial Surgical Site Infection | Deep Surgical Site Infection | Organ/Space Surgical Site InfectionUnited States
-
King Faisal Specialist Hospital & Research CenterEnrolling by invitationSurgical Site Infections | Surgical Site Infection After Major SurgerySaudi Arabia
-
Singapore General HospitalNovem Healthcare Pte LtdTerminatedSuperficial Surgical Site InfectionSingapore
-
Halmstad County HospitalCompleted
-
MinaPharm PharmaceuticalsRecruitingSurgical Site InfectionsEgypt
-
Karolinska University HospitalStockholm South General HospitalRecruitingPostoperative Surgical Site InfectionSweden
-
Washington University School of MedicineCompleted
-
Region SkaneVinnovaCompleted
-
Population Health Research InstituteCompletedSurgical Site InfectionsCanada
-
University of RochesterSage Products, Inc.Completed
Clinical Trials on high-fiber/low fat
-
Tel-Aviv Sourasky Medical CenterUnknownObesity | Diabetes Mellitus, Type 2Israel
-
University of ChicagoRecruiting
-
University of Massachusetts, WorcesterAmerican Cancer Society, Inc.Completed
-
Örebro University, SwedenUniversity of Helsinki; European Innovation CouncilRecruitingHealthy Adults | Dietary Fiber FermentationSweden
-
National Cancer Institute (NCI)Completed
-
BeachbodyGlycemic Index Laboratories, IncCompletedOverweight and ObesityCanada
-
Wageningen University and ResearchJ. Rettenmaier & Sohne GmbH & Co. KGCompleted
-
Washington University School of MedicineCompletedMicrobiota | Gastrointestinal MicrobiomeUnited States
-
Hvidovre University HospitalUniversity of Copenhagen; Danish Research Centre for Magnetic ResonanceCompletedDiabetes | Metabolic Syndrome | NAFLD | Overweight and ObesityDenmark